RSV Vaccines for Senior Adults Linked to Guillain-Barré Syndrome
On Feb. 29, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) presented a preliminary analysis that showed that 23 adults over the age of 65 who received a respiratory syncytial virus (RSV) vaccine developed Guillain-Barré syndrome (GBS).1 When a person develops GBS, including after an infection or […]
CDC Reports Errors in RSV Vaccines Given to Pregnant Woman, Monoclonal Antibody Shots to Children
A new problem involving the RSV (Respiratory Syncytial Virus) vaccines given to adults over age 60 and monoclonal antibody shots given to infants and children has been highlighted in a recent emergency newsletter called the U.S. Centers for Disease Control and Prevention (CDC) Clinician Outreach and Communication Activity, which is distributed to health care providers.1 […]
CDC Recommends Mask Wearing Despite Evidence They Do Not Work and May Cause Harm
The director of the U.S. Centers for Disease Control and Prevention (CDC), Mandy Cohen, MD, MPH is recommending that Americans wear masks to help protect against respiratory diseases such as RSV, COVID-19, pneumonia and influenza that federal health officials say are on the rise again.1 Dr. Cohen advised: To protect yourself and your family this […]
CDC Recommends SIX Vaccines During Pregnancy But Fewer Women are Complying
Fewer women in the U.S. are complying with CDC recommendations to get vaccinated during pregnancy according to a report about an Internet panel survey published on Sept. 29, 2023 in the U.S. Centers for Disease Control and Prevention’s (CDC) Morbidity and Mortality Weekly Report (MMWR). CDC officials analyzed data from the survey assessing the uptake […]
Survey Finds 50 Percent of Americans Will Not Get Influenza Vaccine
A recent survey, which was conducted by the National Foundation for Infectious Diseases (NFID) to better understand the public’s attitudes and beliefs about influenza, COVID-19, respiratory syncytial virus (RSV) and pneumococcal disease, found that many adults in the United States are not concerned about these respiratory diseases. As a result, many Americans do not plan […]
Twelve Infants Die During Clinical Trials for FDA-Endorsed RSV Drug
On June 8, 2023, the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously (21-0) in favor of AstraZeneca and Sanofi’s new nirsevimab (Beyfortus) monoclonal antibody drug believed to provide protection for infants from respiratory syncytial virus (RSV) disease and other lower respiratory tract infections during their first year of life.1 […]
